{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:27:55Z","timestamp":1791037675535,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01663","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T04:45:35Z","timestamp":1594356335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":119,"title":["Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach"],"prefix":"10.3389","volume":"11","author":[{"given":"Anam","family":"Naz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq Tahir","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faryal Mehwish","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0956247819866124","article-title":"Does urbanization make emergence of zoonosis more likely? Evidence, myths and gaps","volume":"31","author":"Ahmed","year":"2019","journal-title":"Environ Urbanization."},{"key":"B2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections\u2014more than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","article-title":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","volume":"20","author":"Wilder-Smith","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1440-1843.2003.00518.x","article-title":"SARS: epidemiology","volume":"8","author":"Chan-Yeung","year":"2003","journal-title":"Respirology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses."},{"key":"B10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerging Microb Infections."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.31.929042","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"bioRxiv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1128\/JVI.03488-13","article-title":"Coronaviruses: important emerging human pathogens","volume":"88","author":"Coleman","year":"2014","journal-title":"J Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jmii.2020.02.001","article-title":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV","volume":"53","author":"Lee","year":"2020","journal-title":"J Microbiol Immunol Infection."},{"key":"B16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","article-title":"In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations","volume":"11","author":"Yang","year":"2015","journal-title":"Hum Vaccines Immunotherap."},{"key":"B17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.apjtm.2016.07.004","article-title":"Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: an in silico approach","volume":"9","author":"Dar","year":"2016","journal-title":"Asian Pacific J Trop Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"120139","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.meegid.2015.03.027","article-title":"Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach","volume":"32","author":"Naz","year":"2015","journal-title":"Infection Genetics Evol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/eji.201445156","article-title":"Redirecting soluble antigen for MHC class I cross presentation during phagocytosis","volume":"45","author":"Hari","year":"2015","journal-title":"Eur J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.vaccine.2015.01.040","article-title":"A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases","volume":"33","author":"Oyarzun","year":"2015","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"D13","DOI":"10.1093\/nar\/gky1069","article-title":"Database resources of the national center for biotechnology information","volume":"40","author":"Sayers","year":"2012","journal-title":"Nucl Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"18.9.1","DOI":"10.1002\/cpim.12","article-title":"TepiTool: a pipeline for computational prediction of T cell epitope candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr Protocols Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"W502","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: immune epitope database\u2014analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucl Acids Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucl Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics."},{"key":"B27","doi-asserted-by":"publisher","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucl Acids Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: a protein\u2013 protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J Am Chem Soc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1080\/07391102.2018.1548977","article-title":"Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics","volume":"37","author":"Srivastava","year":"2019","journal-title":"J Biomol Struct Dyn."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.vaccine.2015.02.053","article-title":"A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein","volume":"33","author":"Guo","year":"2015","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"W72","DOI":"10.1093\/nar\/gki396","article-title":"SCRATCH: a protein structure and structural feature prediction server","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucl Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J Mol Modeling."},{"key":"B33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1385\/1-59259-890-0:571","volume-title":"Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook","author":"Gasteiger","year":"2005"},{"key":"B34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0968-0004(97)01140-7","article-title":"PDBsum: a Web-based database of summaries and analyses of all PDB structures","volume":"22","author":"Laskowski","year":"1997","journal-title":"Trends Biochem Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gr.4086505","article-title":"Galaxy: a platform for interactive large-scale genome analysis","volume":"15","author":"Giardine","year":"2005","journal-title":"Genome Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-4939-7366-8_4","article-title":"YASARA: a tool to obtain structural guidance in biocatalytic investigations","volume":"1685","author":"Land","year":"2018","journal-title":"Protein Eng"},{"key":"B37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1101\/2020.02.19.956581","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell."},{"key":"B38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12985-018-1035-2","article-title":"Human \u03b2-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity","volume":"15","author":"Kim","year":"2018","journal-title":"Virol J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4062\/biomolther.2017.172","article-title":"Towards the application of human defensins as antivirals","volume":"26","author":"Park","year":"2018","journal-title":"Biomol Therapeutics."},{"key":"B40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","article-title":"Toll-like receptors in antiviral innate immunity","volume":"426","author":"Lester","year":"2014","journal-title":"J Mol Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N Engl J Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1016\/j.vaccine.2009.01.072","article-title":"Genome-based approaches to develop vaccines against bacterial pathogens","volume":"27","author":"Serruto","year":"2009","journal-title":"Vaccine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","volume":"15","author":"Sette","year":"2003","journal-title":"Curr Opin Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/emi.2012.1","article-title":"Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines","volume":"1","author":"Shibo","year":"2012","journal-title":"Emerg Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"107477","DOI":"10.1016\/j.jmgm.2019.107477","article-title":"In silico screening of antigenic B-cell derived T-cell epitopes and designing of a multi-epitope peptide vaccine for Acinetobacter nosocomialis","volume":"94","author":"Sajjad","year":"2020","journal-title":"J Mol Graphics Model."},{"key":"B48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","article-title":"Current progress of immunoinformatics approach harnessed for cellular-and antibody-dependent vaccine design","volume":"112","author":"Kazi","year":"2018","journal-title":"Pathogens Global Health."},{"key":"B49","volume-title":"Fundamental Immunology","author":"Paul","year":"2003"},{"key":"B50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1155\/2017\/2680160","article-title":"Fundamentals and methods for T-and B-cell epitope prediction","volume":"2017","author":"Sanchez-Trincado","year":"2017","journal-title":"J Immunol Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1038\/cti.2016.22","article-title":"Toll-like receptors: the swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin Transl Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T04:45:37Z","timestamp":1594356337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2020.01663"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01663","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"article-number":"1663"}}